Spotlight
Obituaries
Classifieds
Families First
VCAs Best of Guide
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Recommended
Clear the Shelters: WRAL, NBC and local animal shelters pet adoption month
Recommended
A painful trade: Swapping wine for THC landed her in the ER and sick for months
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Maze Therapeutics, Inc.
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
July 10, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Tickers
MAZE
Maze Therapeutics to Participate in the Jefferies 2025 Global Healthcare Conference
May 29, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Tickers
MAZE
Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones
May 14, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Tickers
MAZE
Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference
May 13, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Tickers
MAZE
Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights
March 31, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Tickers
MAZE
Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
February 07, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Tickers
MAZE
Maze Therapeutics Announces Pricing of Upsized Initial Public Offering
January 30, 2025
From
Maze Therapeutics, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.